S. V. Wier

发表

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy

R. Fonseca, B. Ness, D. Harrington, 2001, Leukemia.

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations

G. Ahmann, P. L. Bergsagel, R. Fonseca, 2006, Leukemia.

Clinical significance of TP53 mutation in myeloma

R. Fonseca, B. Ness, M. Oken, 2007, Leukemia.

Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma

R. Fonseca, A. Dispenzieri, J. Katzmann, 2010, Leukemia.

Clinical and biological significance of RAS mutations in multiple myeloma

R. Fonseca, B. Ness, M. Oken, 2008, Leukemia.

Genetic aberrations and survival in plasma cell leukemia

P. L. Bergsagel, R. Fonseca, A. Dispenzieri, 2008, Leukemia.

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

G. Ahmann, P. L. Bergsagel, R. Fonseca, 2006, Leukemia.

Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma

J. Carpten, J. Keats, A. Baker, 2010, Leukemia.

6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis

J. Hernández-Rivas, R. Fonseca, A. Dispenzieri, 2007, British journal of haematology.